BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20704146)

  • 1. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.
    Bolton M; Barson W
    Pediatr Ann; 2010 Aug; 39(8):497-503. PubMed ID: 20704146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].
    Kenzel S; Hufnagel M; Berner R; Henneke P
    Dtsch Med Wochenschr; 2010 Jun; 135(23):1198-200. PubMed ID: 20480453
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.
    Madhi SA; Adrian P; Kuwanda L; Jassat W; Jones S; Little T; Soininen A; Cutland C; Klugman KP
    Vaccine; 2007 Mar; 25(13):2451-7. PubMed ID: 17023095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
    Prescrire Int; 2002 Feb; 11(57):7-10. PubMed ID: 11985376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the indirect effects of a pneumococcal vaccine in a community-randomized study.
    Moulton LH; O'Brien KL; Reid R; Weatherholtz R; Santosham M; Siber GR
    J Biopharm Stat; 2006; 16(4):453-62. PubMed ID: 16892907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal conjugated vaccine: PHiD-CV.
    Dinleyici EC; Yargic ZA
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1063-74. PubMed ID: 19883326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal vaccines for infants and children--past, present, and future.
    Klein JO
    Curr Clin Top Infect Dis; 2002; 22():252-65. PubMed ID: 12520657
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fever without source in children 0 to 36 months of age.
    Ishimine P
    Pediatr Clin North Am; 2006 Apr; 53(2):167-94. PubMed ID: 16574521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunization and antimicrobials. Is there an association between the effects against Streptococcus pneumoniae?].
    Aguilar L; Giménez MJ
    Rev Esp Quimioter; 2007 Mar; 20(1):125-7. PubMed ID: 17530045
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain].
    Blanco Quirós A; Giménez Sánchez F; Asensi Botet F; Bernaola Iturbe E; Martín Fde J; García Pérez J; Garcés Sánchez M; Gómez Campderá JA; Picazo JJ; Pineda Solas V;
    An Esp Pediatr; 2002 Oct; 57(4):287-9. PubMed ID: 12392660
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine.
    Ray GT
    Expert Rev Vaccines; 2002 Jun; 1(1):65-74. PubMed ID: 12908513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype distribution of invasive pneumococcal disease during the first 60 days of life.
    Imöhl M; van der Linden M; Mutscher C; Reinert RR
    Vaccine; 2010 Jul; 28(30):4758-62. PubMed ID: 20472027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for other neonatal infections: pneumococcal disease: a major global health problem of young children.
    Richmond P
    Expert Rev Vaccines; 2004 Aug; 3(4):379-82. PubMed ID: 15270639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conjugated pneumococcal vaccine: a clinical profile].
    Di Virgilio R; Zollo A
    Ann Ig; 2001; 13(4 Suppl 3):39-42. PubMed ID: 11760435
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens.
    Mahon BE; Hsu K; Karumuri S; Kaplan SL; Mason EO; Pelton SI; ;
    Vaccine; 2006 Mar; 24(14):2514-20. PubMed ID: 16417951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential criteria for evaluation of pneumococcal conjugate vaccine candidates.
    Paradiso P
    Vaccine; 2009 Aug; 27 Suppl 3():C15-8. PubMed ID: 19683657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.